MEDIORG

Medicamen Organics Share Price

₹63.05
-1.45 (-2.25%)
18 September, 2024 02:41 BSE: NSE: MEDIORG ISIN: INE0PE401018

Start SIP in Medicamen Organics

Start SIP

Medicamen Organics Performance

Day Range

  • Low 63
  • High 65
₹ 63

52 Week Range

  • Low 61
  • High 159
₹ 63
  • Open Price65
  • Previous Close65
  • Volume16000

Medicamen Organics Chart

  • Over 1 Month -13.57%
  • Over 3 Month + 85.44%
  • Over 6 Month + 85.44%
  • Over 1 Year + 85.44%

Medicamen Organics Key Statistics

P/E Ratio
PEG Ratio
Market Cap Cr
Price to Book Ratio 4.9
EPS 2.1
Dividend 0
Relative Strength Index 35.32
Money Flow Index 34.82
MACD Signal -7.61
Average True Range 3.49

Medicamen Organics Investment Rating

  • Master Rating:
  • Medicamen Organics Ltd has an operating revenue of Rs. 68.39 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 13% is healthy, ROE of 15% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 1 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 126 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Medicamen Organics Financials
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr 2523
Operating Expenses Annual Cr 2120
Operating Profit Annual in Cr 52
Depreciation Cr 11
Interest Annual Cr 11
Tax Annual Cr 10
Net Profit Annual Cr 21
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr -4-1
Cash from Investing Activity Annual Cr 00
Cash from Financing Annual Activity Cr 41
Net Cash Flow Annual Cr 00
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr 159
Fixed Assets Annual Cr 1011
Total Non Current Assets Annual Cr 1112
Total Current Assets Annual Cr 2721
Total Assets Annual Cr 3933
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs 1815
ROE Annual % 1611
ROCE Annual % 2418
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 1912
IndicatorMar 2024Mar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2024Mar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2024Mar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2024Mar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Medicamen Organics Technicals

EMA & SMA

Current Price
₹63.05
-1.45 (-2.25%)
pointer
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • ₹67.67
  • 50 Day
  • ₹85.52
  • 100 Day
  • 200 Day
  • 20 Day
  • ₹65.50
  • 50 Day
  • ₹82.67
  • 100 Day
  • 200 Day

Medicamen Organics Resistance and Support

PIVOT
₹63.54
Resistance
First Resistance 64.02
Second Resistance 64.98
Third Resistance 65.47
RSI 35.32
MFI 34.82
MACD Single Line -7.61
MACD -5.82
Support
First Support 62.57
Second Support 62.08
Third Supoort 61.12

Medicamen Organics Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 16,000 1,200,000 75
Week 14,000 1,199,940 85.71
1 Month 39,238 3,066,850 78.16
6 Month 62,504 5,141,584 82.26

Medicamen Organics Result Highlights

Medicamen Organics Synopsis

NSE-Medical-Products

Medicamen Organics belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 25.27 Cr. and Equity Capital is Rs. 8.60 Cr. for the Year ended 31/03/2024. Medicamen Organics Ltd. is a Public Limited Listed company incorporated on 15/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is U74899DL1995PLC066416 and registration number is 066416.
Market Cap 75
Sales 25
Shares in Float 1.17
No of funds
Yield
Book Value 3.65
U/D Vol ratio 0.5
LTDebt / Equity 1
Alpha -1.57
Beta 1.04

Medicamen Organics Shareholding Pattern

Owner Name

Medicamen Organics Management

Name Designation
Mr. Bal Kishan Gupta Chairman & Managing Director
Mr. Ashutosh Gupta Whole Time Director
Mr. Shailesh Harimohan Gaur Executive Director
Mr. Rakesh Kumar Independent Director
Mr. Rajinder Kumar Gupta Independent Director
Mr. Sachin Gupta Independent Director
Ms. Sneh Gaur Non Exe.Non Ind.Director

Medicamen Organics Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Medicamen Organics MF Shareholding

Name Amount(cr)

Medicamen Organics FAQs

What is Share Price of Medicamen Organics ?

Medicamen Organics share price is ₹63 As on 18 September, 2024 | 02:27

What is the Market Cap of Medicamen Organics ?

The Market Cap of Medicamen Organics is ₹73.8 Cr As on 18 September, 2024 | 02:27

What is the P/E ratio of Medicamen Organics ?

The P/E ratio of Medicamen Organics is As on 18 September, 2024 | 02:27

What is the PB ratio of Medicamen Organics ?

The PB ratio of Medicamen Organics is 4.9 As on 18 September, 2024 | 02:27

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form